← Insider buys

Jack W Schuler has bought stock on 101 days since Jan 2016

Emeritus Director at Biodesix, Inc., and 7 other companies

SEC CIK 0001021412 · Filings on SEC.gov ↗

$101.4MBought
$6.4MSold
Aug 13Last buy

Jack W Schuler's record

3 months after each buy, from the first price a copier could get.

−16.2%Average
−18.3 ptsVs S&P 500
5 of 20Higher

20 buys since 2016 with 3 months of prices.

Companies

Every filing

115 filings since Jan 2016, newest first

BDSXBuy

BIODESIX INC

Emeritus Director

$367K+2.8%Aug 13
BDSXBuy

BIODESIX INC

Emeritus Director

$666K+5.4%Aug 12
AWHLBuy

Aspira Women's Health Inc.

10% owner

$100K+5.8%Jun 9
BDSXBuy

Biodesix Inc

Emeritus Director, 10%

$1.2M+5.0%Jan 27
BDSXBuy

Biodesix Inc

Emeritus Director, 10%

$904K+4.0%Jan 26
BDSXBuy

Biodesix Inc

Director and 10% owner

$1.0M+7.0%Sep 23
BDSXBuy

Biodesix Inc

Director and 10% owner

$111K+1.0%Sep 19
AWHLBuy

Aspira Women'S Health Inc.

10% owner

$500K+41.0%Sep 19
BDSXBuy

Biodesix Inc

Director and 10% owner

$1.5M+10.0%Sep 3
BDSXBuy

Biodesix Inc

Director and 10% owner

$1.3M+15.0%May 20
BDSXBuy

Biodesix Inc

Director and 10% owner

$123KNov 22
BDSXBuy

Biodesix Inc

Director and 10% owner

$234K+1.0%Nov 21
BDSXBuy

Biodesix Inc

Director and 10% owner

$137KNov 6
YTENSell

Yield10 Bioscience, Inc.

10% owner

$28K−9.0%Oct 6
BDSXBuy

Biodesix Inc

Director and 10% owner

$217KAug 23
BDSXBuy

Biodesix Inc

Director and 10% owner

$36KJun 1
SLNOSell

Soleno Therapeutics Inc

10% owner

$465K−90.0%May 15
YTENSell

Yield10 Bioscience, Inc.

10% owner

$456K−18.0%May 9
YTENSell

Yield10 Bioscience, Inc.

10% owner

$153K−11.0%May 9
YTENBuy

Yield10 Bioscience, Inc.

10% owner

$1.0M+53.0%May 9
BDSXBuy

Biodesix Inc

Director and 10% owner

$125KJan 31
BDSXBuy

Biodesix Inc

Director and 10% owner

$33KDec 19
BDSXBuy

Biodesix Inc

Director and 10% owner

$313K+1.0%Dec 16
BDSXBuy

Biodesix Inc

Director and 10% owner

$107KDec 15
BDSXBuy

Biodesix Inc

Director and 10% owner

$148K+1.0%Dec 14
SLNOSell

Soleno Therapeutics Inc

10% owner

$488K−15.0%Oct 14
BDSXBuy

Biodesix Inc

Director and 10% owner

$5.0M+33.0%Apr 11
SLNOSell

Soleno Therapeutics Inc

10% owner

$146K−1.0%Apr 4
BDSXBuy

Biodesix Inc

Director and 10% owner

$10.0M+37.0%Jan 31
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$165KJan 20
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$524K+1.0%Jan 18
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$196KJan 12
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$49KJan 6
BDSXBuy

Biodesix Inc

Director and 10% owner

$127KNov 24
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$248KNov 24
BDSXBuy

Biodesix Inc

Director and 10% owner

$390K+1.0%Nov 23
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$295KNov 23
BDSXBuy

Biodesix Inc

Director and 10% owner

$180KNov 22
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$606K+1.0%Nov 22
BDSXBuy

Biodesix Inc

Director and 10% owner

$130KNov 19
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$499KOct 5
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$318KSep 30
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$800K+1.0%Sep 29
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$1.0M+1.0%Sep 28
AXDXBuy

Accelerate Diagnostics, Inc

Director and 10% owner

$150KSep 27
BDSXBuy

Biodesix Inc

Director and 10% owner

$384K+1.0%Aug 23
BDSXBuy

Biodesix Inc

Director and 10% owner

$211KAug 19
BDSXBuy

Biodesix Inc

Director and 10% owner

$1.7M+4.0%Aug 17
SLNOSell

Soleno Therapeutics Inc

10% owner

$3.9M−34.0%Aug 3
YTENBuy

Yield10 Bioscience, Inc.

10% owner

$1.2M+13.0%Feb 4
About Jack W Schuler

Jack W. Schuler is a U.S. healthcare investor and corporate insider who serves as a significant shareholder and 10% owner of Aspira Women's Health Inc. (AWHL), primarily through positions reported in SEC Form 4 filings.( He has accumulated a substantial stake in Aspira via open-market purchases and related warrant positions, reflecting an active role as a long-term strategic investor rather than an operating executive.( Public ownership reports list him as an individual insider, not a corporate entity, and place him among the most influential shareholders across multiple healthcare and diagnostics companies.(

Beyond Aspira Women's Health, Schuler holds or has held large positions and board roles in several publicly traded healthcare and life sciences firms, including QuidelOrtho Corp, Medtronic plc, Stericycle Inc., and others, with an estimated net worth in the hundreds of millions of dollars based on his disclosed holdings.( His investment activity is concentrated in medical technology, diagnostics, and therapeutics companies, where he frequently appears as a director or 10% owner in SEC disclosures, underscoring his profile as a prominent individual investor and board-level participant in the U.S. healthcare sector.( (Publicly available filings and ownership summaries do not provide confirmed details of his formal education.)

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.